When to use tranexamic acid for the treatment of major bleeding?

McQuilten, Zoe K; Wood, Erica M; Medcalf, Robert L

McQuilten, Zoe K; Wood, Erica M; Medcalf, Robert L.

Afiliación

McQuilten ZK; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Department of Haematology, Monash Health, Melbourne, Victoria, Australia. Electronic address: zoe.mcquilten@monash.edu.
Wood EM; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Department of Haematology, Monash Health, Melbourne, Victoria, Australia.
Medcalf RL; Central Clinical School, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.

J Thromb Haemost ; 22(3): 581-593, 2024 Mar.

Article en En | MEDLINE | ID: mdl-37827378

Asunto(s)

Antifibrinolíticos; Hemorragia Posparto; Trombosis; Ácido Tranexámico; Embarazo; Femenino; Humanos; Ácido Tranexámico/efectos adversos; Antifibrinolíticos/efectos adversos; Hemorragia Posparto/tratamiento farmacológico; Hemorragia Posparto/inducido químicamente; Trombosis/tratamiento farmacológico; Trombosis/inducido químicamente; Hemorragia Gastrointestinal/inducido químicamente

Palabras clave

fibrinolysis; major hemorrhage; thrombosis; tranexamic acid; transfusion

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis / Ácido Tranexámico / Hemorragia Posparto / Antifibrinolíticos Límite: Female / Humans / Pregnancy Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google